
Flexsteel Stock Falls 18% in the Session After Its Fiscal First-Quarter Results
Gross margin fell to 22.0%, operating income dropped, and cash fell to $4.4 million, while the company guided to 1% to 4% sales growth next quarter.

Gross margin fell to 22.0%, operating income dropped, and cash fell to $4.4 million, while the company guided to 1% to 4% sales growth next quarter.

The company reported a wider third-quarter net loss and said its TibuSHIELD data remains on track for the fourth quarter of 2026.

MFIC holders would receive $10.88 per share in cash and Ares Capital stock, a 30.1% premium to the prior close.

The equipment rental company raised its full-year 2026 revenue, adjusted EBITDA and capex guidance for the second time this year, citing mega-project demand.

The company's Q3 2026 results included a Q4 Adjusted EBITDA outlook of $10 to 20 million, with operational problems at the Augusta mill continuing into October.

The biotech is also exploring strategic alternatives, including a possible merger, sale or liquidation, after two patient deaths and weaker durability data.